SPONSOR
Corvus Pharmaceuticals, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Conditions studied: Atopic DermatitisAtopic Dermatitis EczemaEczemaEczema, AtopicPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeSystemic Anaplastic Large Cell LymphomaLymphoma, T-Cell, Peripheral
Corvus Pharmaceuticals, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Eczema, Atopic.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Corvus Pharmaceuticals, Inc.
How many clinical trials has Corvus Pharmaceuticals, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Corvus Pharmaceuticals, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Corvus Pharmaceuticals, Inc. research focus on?
Corvus Pharmaceuticals, Inc. clinical trials span Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Eczema, Atopic, Peripheral T-Cell Lymphoma, Not Otherwise Specified, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Corvus Pharmaceuticals, Inc. clinical trial?
To participate in a Corvus Pharmaceuticals, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Corvus Pharmaceuticals, Inc. trials with current recruitment status updated daily.
Clinical Trials by Corvus Pharmaceuticals, Inc.
NCT07441395 Phase 2
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Atopic Dermatitis
NCT06561048 Phase 3
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Peripheral T-Cell Lymphoma, Not Otherwise Specified
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology